tiprankstipranks
GenSight Biologics SA (FR:SIGHT)
:SIGHT
France Market

GenSight Biologics SA (SIGHT) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
GenSight Biologics SA’s (SIGHT) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting GenSight Biologics SA is a Sell.
GenSight Biologics SA’s (SIGHT) 20-Day exponential moving average is 0.25, while GenSight Biologics SA’s (SIGHT) share price is €0.25, making it a Sell.
GenSight Biologics SA’s (SIGHT) 50-Day exponential moving average is 0.27, while GenSight Biologics SA’s (SIGHT) share price is €0.25, making it a Sell.

GenSight Biologics SA (SIGHT) Pivot Points

Mar 13, 2025, 08:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.23
0.24
0.24
0.25
0.25
0.26
0.26
Fibonacci
0.24
0.24
0.24
0.25
0.25
0.25
0.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GenSight Biologics SA (SIGHT) Moving Averages

Mar 13, 2025, 08:28 PM
Period
Simple
Exponential
MA5
0.24Buy
0.24Buy
MA10
0.24Buy
0.24Buy
MA20
0.25Sell
0.25Sell
MA50
0.27Sell
0.27Sell
MA100
0.29Sell
0.29Sell
MA200
0.32Sell
0.32Sell
GenSight Biologics SA’s (SIGHT) 10-Day exponential moving average is 0.24, while GenSight Biologics SA’s (SIGHT) share price is €0.25, making it a Buy.
GenSight Biologics SA’s (SIGHT) 100-Day exponential moving average is 0.29, while GenSight Biologics SA’s (SIGHT) share price is €0.25, making it a Sell.
GenSight Biologics SA’s (SIGHT) stock price is €0.25 and GenSight Biologics SA’s (SIGHT) 50-day simple moving average is 0.27, creating a Sell signal.
GenSight Biologics SA’s (SIGHT) stock price is €0.25 and GenSight Biologics SA’s (SIGHT) 100-day simple moving average is 0.29, creating a Sell signal.
GenSight Biologics SA’s (SIGHT) stock price is €0.25 and GenSight Biologics SA’s (SIGHT) 200-day simple moving average is 0.32, creating a Sell signal.

GenSight Biologics SA (SIGHT) Technical Indicators

Mar 13, 2025, 08:28 PM
Name
Value
Implied Action
RSI (14)
46.75
Neutral
STOCH (9,6)
80.00
Neutral
STOCHRSI (14)
69.87
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
29.52
Neutral
Williams %R
-18.03
Sell
CCI (14)
-8.09
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
52.55
Neutral
ROC
0.00
Sell
GenSight Biologics SA’s (SIGHT) Relative Strength Index (RSI) is 46.75, creating a Neutral signal.
GenSight Biologics SA’s (SIGHT) Trend Strength Indicator (ADX) is 29.52, creating a Neutral signal.
GenSight Biologics SA’s (SIGHT) Commodity Channel Index (CCI) is -8.09, creating a Neutral signal.

FAQ

Is SIGHT a Buy, Hold, or Sell?
Based on SIGHT’s technical indicators, SIGHT is a Sell.
    What is SIGHT’s RSI (14)?
    SIGHT’s RSI (14) is 46.75, which suggests SIGHT is a Neutral.
      What is SIGHT’s MACD?
      SIGHT’s MACD is -0.01, which suggests SIGHT is a Sell.
        What is SIGHT’s 5-day moving average?
        SIGHT’s 5-day moving average is 0.24, which suggests SIGHT is a Buy.
          What is SIGHT’s 20-day moving average?
          SIGHT 20-day moving average is 0.25, which suggests SIGHT is a Sell.
            What is SIGHT’s 50-day moving average?
            SIGHT’s 50-day moving average is 0.27, which suggests SIGHT is a Sell.
              What is SIGHT’s 200-day moving average?
              SIGHT’s 200-day moving average is 0.32, which suggests SIGHT is a Sell.
                What is SIGHT’s Williams % R (14)?
                SIGHT’s Williams % R (14) is -18.03, which suggests SIGHT is a Sell.
                  What is SIGHT’s CCI (14)?
                  SIGHT’s CCI (14) is -8.09, which suggests SIGHT is a Neutral.
                    What is the share price of GenSight Biologics SA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis